Mega Genomics Limited announced that on 17 January 2024, the role of Mr. Huang Yufeng as an executive director of the Company has been terminated with immediate effect pursuant to the article 105(h) of the second amended and restated memorandum and articles of association of the Company by a notice signed by not less than 3/4 in number of the Company's directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.44 HKD | +3.17% | +5.36% | -8.35% |
Mar. 26 | Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 12 | Mega Genomics Stockholders to Vote March 1 on Continuing Transactions | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.35% | 286M | |
-17.86% | 8.35B | |
+41.67% | 3.58B | |
-8.06% | 2.47B | |
-38.71% | 2.46B | |
-7.96% | 2.36B | |
-15.11% | 1.78B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B |
- Stock Market
- Equities
- 6667 Stock
- News Mega Genomics Limited
- Mega Genomics Limited Announces Resignation of Huang Yufeng as an Executive Director